Current Studies / Alzheimer's Disease Neuroimaging Initiative
Purpose:
The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a 5-year public-private partnership to test whether serial magnetic resonance imaging (MRI), positron emission tomography (PET), other biological markers, and clinical and neuropsychological assessment can be combined to measure the progression of mild cognitive impairment and early Alzheimer's disease.
Eligibility Requirements:
Visit Frequency:
Each visit will take approximately 4 hours.
There will be 4 visits if you have been diagnosed with Alzheimer’s disease; 5 visits if you have no problems, and 6 visits if you have mild memory problems.
Compensation:
The costs you incur for time and expenses due to your participation in this study will be compensated. Contact your study site to determine the exact amount of this compensation.
Use of the information and materials on this server is subject to the terms and conditions contained in the Terms of Use and Privacy Statement. By using this web site, you agree to these terms and conditions. Materials on this web site are for informational purposes and are not a substitute for consulting your personal physician.
